Dr. Agarwal's Eye Hospital Statistics
Total Valuation
Dr. Agarwal's Eye Hospital has a market cap or net worth of INR 19.19 billion. The enterprise value is 21.53 billion.
Market Cap | 19.19B |
Enterprise Value | 21.53B |
Important Dates
The next estimated earnings date is Friday, October 18, 2024.
Earnings Date | Oct 18, 2024 |
Ex-Dividend Date | Aug 19, 2024 |
Share Statistics
Dr. Agarwal's Eye Hospital has 4.70 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Shares Outstanding | 4.70M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 3.21% |
Owned by Institutions (%) | n/a |
Float | 1.04M |
Valuation Ratios
The trailing PE ratio is 39.22.
PE Ratio | 39.22 |
Forward PE | n/a |
PS Ratio | 5.63 |
PB Ratio | 12.21 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 44.01 |
EV / Sales | 6.32 |
EV / EBITDA | 21.52 |
EV / EBIT | 31.12 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 170.55 |
Debt / EBITDA | 2.68 |
Debt / FCF | n/a |
Interest Coverage | 8.06 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 11.22% |
Revenue Per Employee | 3.06M |
Profits Per Employee | 439,623 |
Employee Count | 1,113 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.40% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +66.40% |
50-Day Moving Average | 3,757.08 |
200-Day Moving Average | 3,295.21 |
Relative Strength Index (RSI) | 64.97 |
Average Volume (20 Days) | 1,891 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Agarwal's Eye Hospital had revenue of INR 3.41 billion and earned 489.30 million in profits. Earnings per share was 104.11.
Revenue | 3.41B |
Gross Profit | 1.48B |
Operating Income | 691.90M |
Pretax Income | 656.20M |
Net Income | 489.30M |
EBITDA | 1.00B |
EBIT | 691.90M |
Earnings Per Share (EPS) | 104.11 |
Balance Sheet
The company has 337.40 million in cash and 2.68 billion in debt, giving a net cash position of -2.34 billion or -498.47 per share.
Cash & Cash Equivalents | 337.40M |
Total Debt | 2.68B |
Net Cash | -2.34B |
Net Cash Per Share | -498.47 |
Equity (Book Value) | 1.57B |
Book Value Per Share | 334.33 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 43.52%, with operating and profit margins of 20.30% and 14.36%.
Gross Margin | 43.52% |
Operating Margin | 20.30% |
Pretax Margin | 19.26% |
Profit Margin | 14.36% |
EBITDA Margin | 29.36% |
EBIT Margin | 20.30% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.12%.
Dividend Per Share | 5.00 |
Dividend Yield | 0.12% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.13% |
Earnings Yield | 2.55% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |